Rapport Therapeutics (RAPP) Proxy filing summary

Voting matters and shareholder proposals

• Election of James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors is up for vote at the 2026 Annual Meeting.

• Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026 is proposed.

• Proxies are authorized to vote on any other business that may properly come before the meeting or its continuations.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and the auditor ratification.

Audit committee and external auditor matters

• Proposal to ratify PricewaterhouseCoopers LLP as the external auditor for the 2026 fiscal year.